Induction of endogenous Nrf2/small maf heterodimers by arsenic-mediated stress in placental choriocarcinoma cells.
Exposure to inorganic arsenic has been associated with various forms of cancer, nervous system pathogenesis, and vascular diseases, as well as reproductive and developmental toxicity. Here, the effect of inorganic arsenic on placental JAR choriocarcinoma cells was assessed. The nuclear protein levels of the CNC transcription factor Nrf2 were strongly induced in the presence of arsenic. Dosage response experiments showed that 0.5 microM of arsenic is sufficient to augment Nrf2 levels. The expression of the Nrf2 dimerization partners MafG and MafK appeared not to be modulated by arsenic, whereas MafF protein levels were slightly increased. Arsenic also induced the binding of endogenous Nrf2/small Maf DNA-binding complexes to a stress response element (StRE) recognition site. In addition, arsenic caused oxidative stress in the choriocarcinoma cell model as evidenced by an increase in intracellular H2O2 levels. Expression of the enzyme heme oxygenase-1 (HO-1), a known Nrf2 target gene, was upregulated by exposure of JAR cells to arsenic. These results suggest that Nrf2/small Maf heterodimers may play an important role in the response to arsenic-mediated stress in placental cells.
Lady Davis Institute for Medical Research, McGill University, Montreal, Quebec, Canada.
Wael
W
Massrieh
Anna
A
Derjuga
Volker
V
Blank
D001151:Arsenic / Q000633:toxicity*; D002460:Cell Line; D045744:Cell Line, Tumor; D002822:Choriocarcinoma / Q000503:physiopathology*; D017931:DNA Primers; D019281:Dimerization; D004622:Embryo, Mammalian; D005260:Female; D006801:Humans; D007668:Kidney; D007700:Kinetics; D051260:MafF Transcription Factor / Q000378:metabolism; D051267:NF-E2-Related Factor 2 / Q000096:biosynthesis* / Q000187:drug effects; D009687:Nuclear Proteins / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D010920:Placenta / Q000187:drug effects / Q000503:physiopathology*; D010957:Plasmids; D011247:Pregnancy; D051257:Proto-Oncogene Proteins c-maf / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014594:Uterine Neoplasms / Q000503:physiopathology*
D017931:DNA Primers; C495607:MAF protein, human; C484147:MAFF protein, human; D051260:MafF Transcription Factor; D051267:NF-E2-Related Factor 2; D009687:Nuclear Proteins; D051257:Proto-Oncogene Proteins c-maf; D001151:Arsenic